Table IV.
Group | Case, n | Median survival time (months) | 1 year survival (%) | u-value | P-value |
---|---|---|---|---|---|
LNα3 | 4.941 | 0.026 | |||
Low | 26 | 18.434 | 57 | ||
High | 52 | 7.911 | 21 | ||
LNγ2 | 8.248 | 0.004 | |||
Low | 38 | 18.961 | 60 | ||
High | 40 | 7.234 | 14 | ||
LNα3/LNβ3/LNγ2 | 9.996 | 0.002 | |||
Others | 39 | 19.373 | 61 | ||
Patterns of LNγ2 | |||||
B-type | 17 | 34.000 | 70 | 4.059 | 0.044 |
C-type | 46 | 10.540 | 32 | ||
B-type | 17 | 34.000 | 70 | 6.247 | 0.012 |
M-type | 15 | 6.271 | 9 | ||
C-type | 46 | 10.540 | 32 | 1.861 | 0.173 |
M-type | 15 | 6.271 | 9 |
Gehan test score was used for univariate analyses. LNα3, laminin α3; LNβ3, laminin β3; LNγ2, laminin γ2; B-type, basement membrane type; C-type, cytoplasmic type; M-type, mixed type.